Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,124.35
(
0.21%
)
US TECH 100
25,895.20
(
0.09%
)
Dow Jones
49,802.47
(
0.72%
)
Brent Oil
91.82
(
1.26%
)
Bitcoin
75,824.10
(
-0.09%
)
News Focus
News Focus
Post# of 257432
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: xrymd post# 216470

Tuesday, 01/09/2018 12:53:09 PM

Tuesday, January 09, 2018 12:53:09 PM

Post# of 257432
APOP has very little trading volume on Nasdaq. The “average volume” figure is badly skewed by the 3.8M shares traded on 1/4/17, when APOP rose 27% on the heels of an “n=3” PR purporting to show proof of concept:

https://finance.yahoo.com/news/cellect-announces-breakthrough-clinical-results-124500349.html

If one were so inclined, it might be possible to accumulate a sizable position over time, but it would be tough to unload if things didn’t work out.

I don’t have an educated opinion on the company’s technology. If anyone does, please post.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today